TQT2 Study to Evaluate the Effect of MD1003 on Cardiac Repolarization in Healthy Adult Subjects
Clinical trial NCT04168723 · UNKNOWN
Trial details
- NCT number
- NCT04168723
- Sponsor
- MedDay Pharmaceuticals SA
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-11
- Primary completion
- 2020-03-05
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.